Type
. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1979;47(1):37-43.
Type
. Fluorescence microscopy for detection of M. leprae in tissue sections. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1979;47(1):33-6.
Type
. Respiratory system involvement in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1979;47(1):18-25.
Type
. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy. Leprosy in India. 1979;51(1):8-22.
Type
. Histopathologic study of clinically normal appearing skin in lepromatous leprosy. Leprosy in India. 1979;51(1):78-80.
Type
. The role of macrophages in leprosy as studied by protein synthesis of macrophages from resistant and susceptible hosts--a mouse and human study. Leprosy in India. 1979;51(1):23-42.
Type
. Leprosy-like disease of wild armadillos in French Acadiana, Louisiana. Journal of the Reticuloendothelial Society. 1978;24(6):705-19.
Type
. Assessment of Dharmendra antigen. Leprosy in India. 1978;50(4):599-609.
Type
. Concluding comments on development of a vaccine against leprosy. Leprosy in India. 1978;50(4):597-8.
Type
. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria. Leprosy in India. 1978;50(4):572-8.